{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:37:20Z","timestamp":1782254240068,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":6434,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1111\/j.1538-7836.2005.01269.x","type":"journal-article","created":{"date-parts":[[2005,4,29]],"date-time":"2005-04-29T06:06:02Z","timestamp":1114754762000},"page":"1088-1089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Temporary relief of symptomatic Von Willebrand disease by multiple myeloma"],"prefix":"10.1016","volume":"3","author":[{"given":"J.J.A.","family":"AUWERDA","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"SONNEVELD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.W.G.","family":"LEEBEEK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1538-7836.2003.00083.x","article-title":"Extremely high levels of Von Willebrand factor antigen and of procoagulant factor VIII found in multiple myeloma patients are associated with activity status but not with thalidomide treatment","volume":"1","author":"Minnema","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0015","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0889-8588(18)30276-4","article-title":"Hemostatic abnormalities in multiple myeloma and related disorders","volume":"6","author":"Glaspy","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0020","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00001721-199509000-00010","article-title":"Acquired Von Willebrand disease associated with multiple myeloma: characterisation of an inhibitor to Von Willebrand factor","volume":"6","author":"Mohri","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0025","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1182\/blood.V98.5.1614","article-title":"Increased risk of deep\u2010vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy","volume":"98","author":"Zangari","year":"2001","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0030","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1182\/blood-2002-01-0335","article-title":"Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy","volume":"100","author":"Zangari","year":"2002","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0035","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.ATV.21.5.731","article-title":"Elevated factor VIII levels and the risk of thrombosis","volume":"21","author":"Kamphuisen","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0040","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0093-7754(01)90022-3","article-title":"Bone marrow angiogenesis in patients with active multiple myeloma","volume":"28","author":"Vacca","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1046\/j.1365-2141.2001.02738.x","article-title":"Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma","volume":"113","author":"Vacca","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1538-7836.2005.01269.x_bb0050","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.71.5.1906","article-title":"Synthesis of von Willebrand factor by cultured human endothelial cells","volume":"71","author":"Jaffe","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"issue":"Suppl. 3","key":"10.1111\/j.1538-7836.2005.01269.x_bb0055","first-page":"7","article-title":"Optimizing therapy with Factor VIII\/Von Willebrand factor concentrates in von Willebrand disease","volume":"4","author":"Federici","year":"1988","journal-title":"Haemophilia"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2005.01269.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622159763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622159763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2005.01269.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:33:58Z","timestamp":1761532438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622159763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S1538783622159763"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01269.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporary relief of symptomatic Von Willebrand disease by multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01269.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}